Total Payments
$1,147
2024 Payments
$15.36
Companies
12
Transactions
41
Medicare Patients
1,341
Medicare Billing
$107,861
Payment Breakdown by Category
Food & Beverage$1,138 (99.2%)
Education$9.09 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,138 | 40 | 99.2% |
| Education | $9.09 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $358.96 | 3 | $0 (2022) |
| ABBVIE INC. | $181.89 | 9 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $137.75 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $119.07 | 2 | $0 (2022) |
| PFIZER INC. | $78.10 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $69.86 | 4 | $0 (2022) |
| Celgene Corporation | $62.20 | 4 | $0 (2022) |
| INTERCEPT PHARMACEUTICALS, INC. | $42.84 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $41.46 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $22.06 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.36 | 1 | PFIZER INC. ($15.36) |
| 2023 | $81.17 | 4 | PFIZER INC. ($25.10) |
| 2022 | $602.58 | 18 | Janssen Pharmaceuticals, Inc ($234.81) |
| 2021 | $448.24 | 18 | AbbVie Inc. ($151.35) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/09/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/09/2023 | Enterra Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.08 | General |
| 03/29/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/14/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: HCV | ||||||
| 11/15/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Immunology | ||||||
| 11/09/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/19/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/08/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Neuroscience | ||||||
| 08/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/13/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Immunology | ||||||
| 05/26/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: IMMUNOLOGY | ||||||
| 04/21/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/18/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/13/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/06/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Neuroscience | ||||||
| 03/24/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/08/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $109.98 | General |
| Category: Neuroscience | ||||||
| 02/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 01/04/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Neuroscience | ||||||
| 12/16/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/24/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 335 | 386 | $53,787 | $21,022 |
| 2022 | 4 | 679 | 905 | $111,090 | $58,153 |
| 2021 | 3 | 327 | 387 | $48,015 | $28,686 |
Total Patients
1,341
Total Services
1,678
Medicare Billing
$107,861
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 176 | 220 | $22,132 | $9,385 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 91 | $15,674 | $6,151 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $14,541 | $4,836 | 33.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 16 | 16 | $1,440 | $648.80 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 413 | 619 | $61,900 | $34,322 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 119 | 119 | $24,990 | $11,735 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 152 | $22,040 | $11,154 | 50.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,160 | $942.40 | 43.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 200 | 245 | $24,500 | $15,098 | 61.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 97 | $14,065 | $8,543 | 60.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $9,450 | $5,044 | 53.4% |
About Kelsey Glover, PA-C
Kelsey Glover, PA-C is a Medical healthcare provider based in Portland, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2021. The National Provider Identifier (NPI) number assigned to this provider is 1265026041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelsey Glover, PA-C has received a total of $1,147 in payments from pharmaceutical and medical device companies, with $15.36 received in 2024. These payments were reported across 41 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,138).
As a Medicare-enrolled provider, Glover has provided services to 1,341 Medicare beneficiaries, totaling 1,678 services with total Medicare billing of $107,861. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Portland, TN
- Active Since 02/23/2021
- Last Updated 03/06/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1265026041
Products in Payments
- XARELTO (Drug) $358.96
- ZEPOSIA (Drug) $181.27
- LINZESS (Drug) $159.90
- ZENPEP (Drug) $137.75
- ENTYVIO (Biological) $69.86
- XELJANZ (Drug) $62.74
- OCALIVA (Drug) $42.84
- STELARA (Biological) $41.46
- Epclusa (Drug) $22.06
- RINVOQ (Biological) $17.61
- PAXLOVID (Drug) $15.36
- Talicia (Drug) $12.08
- CREON (Drug) $4.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Portland
Mrs. Britt Benn, Ms, Rpa-C, MS, RPA-C
Medical — Payments: $8,980
Medical $8,980
Jannelle Fukuji, Pa-C, PA-C
Medical — Payments: $6,052
Medical $6,052
Ms. Kimberly Sanders, Physician Assistant, PHYSICIAN ASSISTANT
Medical — Payments: $5,496
Medical $5,496
Erica Ballard
Medical — Payments: $5,015
Medical $5,015
Mr. Christopher Killen, Pa-C, PA-C
Medical — Payments: $4,765
Medical $4,765
Margaret Ng, Pac, PAC
Medical — Payments: $3,410
Medical $3,410